SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-009610
Filing Date
2024-02-01
Accepted
2024-02-01 07:18:00
Documents
1
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4342
  Complete submission text file 0000950170-24-009610.txt   5809
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Sabag Mark (Reporting) CIK: 0001721442 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 24585025